TIME-COURSE OF CYTOKINE LEVELS IN SEPSIS

被引:138
作者
THIJS, LG
HACK, CE
机构
[1] FREE UNIV AMSTERDAM HOSP,INST CARDIOVASC RES,1007 MB AMSTERDAM,NETHERLANDS
[2] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS
关键词
CYTOKINES; SEPSIS; MEDIATORS;
D O I
10.1007/BF01740764
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
In severe sepsis, a network of proinflammatory cytokines (TNF, IL-1 beta, IL-6, IL-8) is activated and blood levels of these cytokines are elevated, albeit inconsistently and with large individual variations. In addition, elevated blood levels of anti-inflammatory cytokines (IL-10), as well as of soluble cytokine receptors (sTNF-RI and II, IL-lra), have been found. They seem to have a regulatory function in the host response. Levels of TNF and IL-6 are usually highest at the time of admission, whereas the time course of IL-1 beta levels (when detectable) can vary considerably. Limited data on IL-8 levels suggest that they may remain elevated for longer periods. Elevated levels of sTNFR and IL-lra may also persist for a prolonged period of time. The pathogenetic significance of these observations is still unclear, but persistingly high levels of proinflammatory cytokines may be associated with organ failure and mortality.
引用
收藏
页码:S258 / S263
页数:6
相关论文
共 31 条
  • [1] INTERLEUKIN-10 PROTECTS MICE AGAINST STAPHYLOCOCCAL-ENTEROTOXIN B-INDUCED LETHAL SHOCK
    BEAN, AGD
    FREIBERG, RA
    ANDRADE, S
    MENON, S
    ZLOTNIK, A
    [J]. INFECTION AND IMMUNITY, 1993, 61 (11) : 4937 - 4939
  • [2] HIGH CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH SEPTIC SHOCK - EVOLUTION DURING SEPSIS, PROGNOSTIC VALUE, AND INTERPLAY WITH OTHER CYTOKINES
    CALANDRA, T
    GERAIN, J
    HEUMANN, D
    BAUMGARTNER, JD
    GLAUSER, MP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) : 23 - 29
  • [3] PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK
    CALANDRA, T
    BAUMGARTNER, JD
    GRAU, GE
    WU, MM
    LAMBERT, PH
    SCHELLEKENS, J
    VERHOEF, J
    GLAUSER, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) : 982 - 987
  • [4] CIRCULATING INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR IN SEPTIC SHOCK AND EXPERIMENTAL ENDOTOXIN FEVER
    CANNON, JG
    TOMPKINS, RG
    GELFAND, JA
    MICHIE, HR
    STANFORD, GG
    VANDERMEER, JWM
    ENDRES, S
    LONNEMANN, G
    CORSETTI, J
    CHERNOW, B
    WILMORE, DW
    WOLFF, SM
    BURKE, JF
    DINARELLO, CA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01) : 79 - 84
  • [5] PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME
    CASEY, LC
    BALK, RA
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 771 - 778
  • [6] HIGH-LEVELS OF INTERLEUKIN-8 IN THE BLOOD AND ALVEOLAR SPACES OF PATIENTS WITH PNEUMONIA AND ADULT-RESPIRATORY-DISTRESS-SYNDROME
    CHOLLETMARTIN, S
    MONTRAVERS, P
    GIBERT, C
    ELBIM, C
    DESMONTS, JM
    FAGON, JY
    GOUGEROTPOCIDALO, MA
    [J]. INFECTION AND IMMUNITY, 1993, 61 (11) : 4553 - 4559
  • [7] TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SERUM LEVELS DURING SEVERE SEPSIS IN HUMANS
    DAMAS, P
    REUTER, A
    GYSEN, P
    DEMONTY, J
    LAMY, M
    FRANCHIMONT, P
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (10) : 975 - 978
  • [8] CYTOKINE SERUM LEVEL DURING SEVERE SEPSIS IN HUMAN IL-6 AS A MARKER OF SEVERITY
    DAMAS, P
    LEDOUX, D
    NYS, M
    VRINDTS, Y
    DEGROOTE, D
    FRANCHIMONT, P
    LAMY, M
    [J]. ANNALS OF SURGERY, 1992, 215 (04) : 356 - 362
  • [9] PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS
    DEBETS, JMH
    KAMPMEIJER, R
    VANDERLINDEN, MPMH
    BUURMAN, WA
    VANDERLINDEN, CJ
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (06) : 489 - 494
  • [10] PLASMA TUMOR NECROSIS FACTOR LEVELS IN PATIENTS WITH PRESUMED SEPSIS - RESULTS IN THOSE TREATED WITH ANTILIPID-A ANTIBODY VS PLACEBO
    DEGROOTE, MA
    MARTIN, MA
    DENSEN, P
    PFALLER, MA
    WENZEL, RP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (02): : 249 - 251